Recruiting nowN/AAges 13 Years and up
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Sponsor: Ricoh USA, Inc. · NCT06387485 on ClinicalTrials.gov ↗
Conditions studied
Sarcoma, EwingChondrosarcomaOsteosarcomaFibrous HistiocytomaFibrosarcoma
What it tests
- 3D Printed Anatomic Modeldevice
- CT/MRIdiagnostic_test
Where it's running3 sites
- Recruiting now
Kaiser Permanente Oakland Medical Center
Oakland, California 94611
- Rozhin Lak(contact)925-922-8575[email protected]
- Recruiting now
William Beaumont University Hospital
Royal Oak, Michigan 48073
- Pamela Sloan, RN, CCRP(contact)248-551-6059[email protected]
- Recruiting now
The Ohio State University Wexner Medical Center
Columbus, Ohio 43212
- Rachel Herster, BS(contact)248-514-4490[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: 1. Subjects must be at least 13 years of age. 2. Subjects must have the ability to provide written informed consent. 3. Subjects must have tumor(s) invading bone and requiring surgical excision including but not limited to craniomaxillofacial, spine, long bone, and pelvis. 4. Subjects must be willing to have quality cross-sectional imaging that will allow for use to develop a 3D printed model. Exclusion Criteria: 1. Pregnant or nursing women. 2. Subjects that have a serious systemic pathology. 3. Subjects that have clotting disorders. 4. Subjects that have uncontrolled hypertension. 5. Subjects that are HIV-positive. 6. Subjects that are unable to be randomized; i.e surgical team prefers to use either 3D model or standard cross-sectional imaging for surgical pre-planning. 7. Subject anatomy has changed substantially since the date medical imaging from which the model is derived was obtained (as applicable). 8. Subject is a poor surgical or poor study candidate which may include, any medical, social or psychological problem that could complicate the procedure.
Updated 2026-02-06 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.